Get the Stockscreener App
17.75
1.93%
-0.35
After Hours:
16.87
-0.88
-4.96%
Why is Travere Therapeutics Inc (TVTX) Stock down?
We've noticed a 5.06% decline in Travere Therapeutics Inc (TVTX) stock during the 2024-10-07 trading session. While this could be attributed to normal volatility or various internal and external factors, please be aware that we are actively monitoring the situation, and we'll provide timely updates as soon as possible!
21 Sep, 2023:
Travere Therapeutics, Inc. (TVTX) shares dipped 40.7% to $7.64 after the company announced topline two-year confirmatory secondary endpoint results from its head-to-head Phase 3 PROTECT Study of Filspari (sparsentan) in IgA nephropathy (IgAN) versus Sanofi SA's Avapro (irbesartan).
2.02%
0.47%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):